Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM229A encodes a protein referred to as “Family with sequence similarity 229 member A,” with a molecular weight of ~13 kDa[3]. It is a human gene and protein identified through genome sequencing and bioinformatics, and is primarily annotated in functional genomics and protein expression databases[5][1][7][3]. The protein’s structure has been predicted by AlphaFold, but its molecular function and cellular role remain unknown[3][6]. No experimentally validated biological processes, disease associations, or drug interactions have been published for FAM229A. Current protein databases classify it as "other" due to lack of functional characterization[6][2].
None reported (no mechanism of action for any drugs, as it is not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 229 member A (FAM229A).